All News

Persistent high-level EBNA-1 peptide antibody titers could be used to identify multiple sclerosis (MS) vs neuromyelitis optica spectrum disorder (NMOSD).

A study of 46 million visits finds telemedicine remains above prepandemic levels, but older adults and minority groups are less likely to use virtual care.

The efficacy and safety of efgartigimod in pediatric patients will need to be further validated with future studies.

Ajai Chari, MD, discusses how the results of the MajesTEC-3 trial may translate to a real-world second-line population with multiple myeloma.

Intensive lifestyle programs for childhood obesity can prevent long-term chronic disease.

Federal RHTP funding often misses states with the highest rural mortality and greatest projected Medicaid funding losses, researchers found.

Clinicians must consider patient comorbidities and therapy safety when selecting immunotherapy for cSCC, says Todd Schlesinger, MD.

Noah Greenspan, DPT explains challenges diagnosing long COVID and strategies like pacing, compression, and electrolytes to support recovery.

A deeper understanding of vitiligo's autoimmune mechanisms has fundamentally transformed vitiligo care, explains Susan Taylor, MD.

Roberto Mina, MD, details how in the MajesTEC-9 trial, teclistamab monotherapy boosted PFS and OS in relapsed/refractory multiple myeloma, challenging standardized care.

Domain Adaptation leverages lymphoma EHRs to better predict infection risk from treatment-related immune suppression in CLL, boosting Matthews correlation coefficient.

The FDA approved kinase inhibitors, biologics, a pancreatic cancer device, GLP-1 updates, and a new ultrarare disease pathway in February 2026.

Elona Toska, MSc, DPhil, explores drivers of HIV in pregnant women and young mothers: biology, relationships, and postpartum treatment drop-off.

New data tracks young-onset colorectal cancer, Medicaid health gaps, pediatric diabetes spikes, and drug-pricing shifts reshaping US care in 2026 highlight this weekly roundup.

The politicization of public health is eroding vaccine confidence, risking lower uptake and potential disease outbreaks, says Noel T. Brewer, PhD.

Racial disparities in food insecurity persisted despite income level in US households between 2000 and 2023.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Experts unpacked MFN drug pricing, expired ACA subsidies, and IRA fallout for community oncology in a recent webinar.

Sequencing CDK4/6i to the second line rather than the first appears to produce equivalent survival for most patients with meaningfully less treatment burden.

Immunotherapies are transforming treatment and improving outcomes for patients with advanced cSCC, according to Todd Schlesinger, MD.

A Cleveland Clinic study shows a medically trained AI system can rapidly screen electronic health records to identify eligible participants for rare disease clinical trials.

A new study finds one-third of ambulatory patients with heart failure with reduced ejection fraction overestimate their life expectancy.

Teclistamab had received an accelerated approval in October 2022; the combination regimen is administered subcutaneously.

In a cohort of US veterans, there were reduced risks of adverse clinical outcomes in people with SUDs and of developing an SUD in those taking GLP-1s.

The rise in CRC in adults younger than 65 underscores the need for early screening and prevention efforts.

Patient-reported data can predict survival in leukemia, and integrating measuring tools improves care by prioritizing the patient's perspective.

A study of 1.5 million patients suggests that ACA Medicaid expansion reduces breast cancer deaths, especially advanced cases—yet racial and income gaps persist.

The approval is expected to offer more affordable treatment options and potentially reduce asthma-related complications nationwide.